PPT-Advances in the Multidisciplinary Management of Hepatocellular Carcinoma:

Strategies for Incorporating Emerging Immunotherapy Treatment Options Patient Case 1 65yearold otherwise healthy man with history of HCV In screening noted to have a 21 cm hypervascular. Hilda T Marima- Matarira. Professor of Chemical Pathology. University of Zimbabwe. Objectives. To . evaluate the clinical utility of biochemical . tests. , . ie.. Alpha-Fetoprotein . (AFP) , . Alkaline Phosphatase . Erin Alesi, MD. Medical Oncology and Palliative Medicine. Objectives. Review anatomy of the nasopharynx. Discuss epidemiology of nasopharyngeal (NP) carcinoma. Discuss etiology and risk factors. Review histology. risk factors and pathogenesis. Dr Richard Phillips. KNUST/KATH. Introduction. 0.25-1.2 million . cases worldwide per . year. 5. th. most common human cancer. . 80% of burden in developing countries. Authors. : . Federico Piñero. 1,11,12. , Fernando Rubinstein. 15. , . Sebastián. Marciano. 2. , Nora Fernández. 5. , Jorge Silva. 10. , . Yanina. Zambelo. 8. , Margarita Anders. 4. , . Alina. Zerega. Serum Squamous . Cell Carcinoma Antigen (SCCA) for Prediction of HCC Patients . Presented . By:. Sally Saad Mandour Esawy. Ass. . Lecturer of Clinical Pathology. National Liver Institute, . Menoufia. Curtis Barry, MD. UMASS ECHO. April 21, 2017. Ascites. The Development of Ascites. Revised Underfill. . Peripheral vasodilation occurs as the result of decreased hepatic clearance of vasodilators such as glucagon and NO. Presented by:. Dr. . Iram. Naseer. Moderated by:. Prof .. Iqbal. Aziz. . BREAST CARCINOMA. •Breast cancer is most . common. malignancy . in . female. . •Second to lung . cancer. •Now the mortality rate . estimate that, in 2030, liver cancer will be the thirdleading cause of cancerrelated deaths, surpassing breast, colorectal, and prostate cancers.xivxvAlthough liver cancer remains one of the few cance ● ● CBC with differential , liver function test ( LFTs ) , c reatinine , electrolytes , PT / INR , lipid profile , hemoglobin A 1 C , alpha - fetoprotein ( AFP ) ● Viral serologies if 4874 Key words (MeSH)Carcinoma hepatocellularMagnetic resonance Liver neoplasms Palabras clave (DeCS)Carcinoma hepatocelularImagen por resonancia Neoplasias hepáticas Magnetic Resonance Imaging of th Mark . Sonderup and Douglas LaBrecque*. Division of Hepatology, Department of Medicine, . University of Cape Town and Groote Schuur Hospital. Cape Town, South . Africa. *Emeritus Professor of Internal Medicine, Gastroenterology and Hepatology. in Hepatocellular Carcinoma: . Real-World Experience and Treatment Sequencing with NASH/NAFLD Risk Factors. Sammy Saab, . MD, MPH, AGAF, FACG, FAASLD. Medical Director, Pfleger Liver Institute. Medical Director, Adult Liver Transplant Program. Hepatocellular Carcinoma. Risk factors for HCC. HBV – the most common causative risk factor. Increased risk :. Earlier infection. Higher DNA load (>2000 IU/L). Higher level of quant. . HbsAg. (>10,000 U/L).